Analysis Report #SUNPHARMA

Stock Analysis : Sun Pharmaceutical Industries Ltd.

Overview :
Sun Pharmaceutical Industries Limited (NSE: SUNPHARMA, BSE: 524715) is an Indian multinational pharmaceutical company headquartered in Mumbai, Maharashtra that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) primarily in India and the United States. The company offers formulations in various therapeutic areas, such as cardiology, psychiatry, neurology, gastroenterology and diabetology. It also provides APIs such as warfarin, carbamazepine, etodolac, and clorazepate, as well as anticancers, steroids, peptides, sex hormones, and controlled substances.

Technical View :
Sun Pharma is cracking 7-8% from 563 to 515 ahead of the US FDA inspection scheduled in next few days. No One knows what’s the outcome. However Technically, the overall structure of the charts is weak.
Stock has broken an important support 540 joining the rising trend-line support from lows of 430 (Aug 2017) & 499 (Dec 2017) & on its way to test its next major support 507-515 which is 61.8% Fibonacci Retracement of the entire up move from 95 (March 2009) to 1200 (April 2015).
Currently 550-560 is the resistance & breach below 507 may further deteriorate the overall prevailing technical structure over last 1 year.

Below 507, stock can test 460-450 zone.

Medium Term Reversal only likely above 560.



Comments

  1. UnknownFebruary 20, 2018 at 11:06 PM

    Hii

    Please share me your twitter handle id , Your message is rotating on whatsapp.

    ReplyDelete

Post a Comment

Popular posts from this blog

Analysis Report #CNX Nifty 50

Image
www.jskfin.com NIFTY Analysis Overview : The NIFTY 50 index is National Stock Exchange of India's benchmark broad based stock market index for the Indian equity market. It represents the weighted average of 50 Indian large cap company stocks. Nifty is owned and managed by India Index Services and Products (IISL) , which is a wholly owned subsidiary of the NSE Strategic Investment Corporation Limited. IISL had a marketing and licensing agreement with Standard & Poor's for co-branding equity indices until 2013. The Nifty 50 was launched on 21st April 1996.  NIFTY 50 is the world’s most actively traded contract. Today, Dalal Street seen the bloodbath after the huge rally from last couple of days.  Nifty 50 declined 256.30 points, or 2.33% and closes at 10,760.60 .  On the last day of the week and ahead of budget investor get disappointed and sells the equity worth over 5 lakh crore. The main cause of this disappointment is  the LTCG (Long Term Ca...
Read more

Dan Zanger’s 10 Golden Rules

1. Make sure the stock has a well formed base or pattern. 2.Buy the stock as it moves over the trend line of that base or pattern and make sure that volume is above recent trend shortly after this "breakout" occurs. Never pay up by more than 5% above the trend line. You should also get to know your stock's thirty day moving average volume. 3.Be very quick to sell your stock should it return back under the trend line or breakout point. Usually stops should be set about $1 below the breakout point. The more expensive the stock, the more leeway you can give it, but never have more than a $2 stop loss. Some people employ a 5% stop loss rule. This may mean selling a stock that just tried to breakout and fails in 20 minutes or 3 hours from the time it just broke out above your purchase price. 4.Sell 20 to 30% of your position as the stock moves up 15 to 20% from its breakout point. 5.Hold your strongest stocks the longest and sell stocks that stop moving up or are acting sl...
Read more